| Rishi Kranth Vasireddy, MBBS | |
|
1035 Bellevue Ave, Suite 305, Saint Louis, MO 63117-1854 | |
| (314) 925-4741 | |
| (314) 925-4754 |
| Full Name | Rishi Kranth Vasireddy |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | 1035 Bellevue Ave, Saint Louis, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053547539 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2015017953 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health St Mary's Hospital - St Louis | Richmond heights, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ssm Medical Group Inc | 6608776299 | 491 |
News Archive
Clinical Therapeutics features a special report in its April issue focusing primarily on the behavioral issues associated with patients' self-management of type 2 diabetes.
The COVID-19 pandemic is having a detrimental impact on substance use, mental health, and weight-related health behaviors among people with obesity, according to a new study by researchers at UT Southwestern and the UTHealth School of Public Health.
Betty Jones voted for President Donald Trump in 2016, but the lifelong Republican has her doubts she will do it again this year.
Watson Pharmaceuticals, Inc. today announced that the results of an open-label extension of two Phase 3 studies, published in the December issue of the peer-reviewed journal Urology, demonstrate long-term safety and tolerability of RAPAFLO® (silodosin) for up to 52 weeks of treatment. RAPAFLO® is an effective and uniquely selective alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), the number one reason patients visit urologists.
Cancer-related fatigue is often a major problem for cancer patients, beginning at diagnosis, during treatment and after completing therapy. Researchers at Mayo Clinic and the North Central Cancer Treatment Group (NCCTG) recently completed a study testing methylphenidate in the treatment of cancer-related fatigue and found that, while it did not improve fatigue for a broad group of patients, the data did not rule out a benefit for those with stage III/IV cancer.
› Verified 9 days ago
| Entity Name | Ssm Health Care St Louis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275586174 PECOS PAC ID: 7810800737 Enrollment ID: O20031118000393 |
News Archive
Clinical Therapeutics features a special report in its April issue focusing primarily on the behavioral issues associated with patients' self-management of type 2 diabetes.
The COVID-19 pandemic is having a detrimental impact on substance use, mental health, and weight-related health behaviors among people with obesity, according to a new study by researchers at UT Southwestern and the UTHealth School of Public Health.
Betty Jones voted for President Donald Trump in 2016, but the lifelong Republican has her doubts she will do it again this year.
Watson Pharmaceuticals, Inc. today announced that the results of an open-label extension of two Phase 3 studies, published in the December issue of the peer-reviewed journal Urology, demonstrate long-term safety and tolerability of RAPAFLO® (silodosin) for up to 52 weeks of treatment. RAPAFLO® is an effective and uniquely selective alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), the number one reason patients visit urologists.
Cancer-related fatigue is often a major problem for cancer patients, beginning at diagnosis, during treatment and after completing therapy. Researchers at Mayo Clinic and the North Central Cancer Treatment Group (NCCTG) recently completed a study testing methylphenidate in the treatment of cancer-related fatigue and found that, while it did not improve fatigue for a broad group of patients, the data did not rule out a benefit for those with stage III/IV cancer.
› Verified 9 days ago
| Entity Name | Ssm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700966207 PECOS PAC ID: 6608776299 Enrollment ID: O20040729001034 |
News Archive
Clinical Therapeutics features a special report in its April issue focusing primarily on the behavioral issues associated with patients' self-management of type 2 diabetes.
The COVID-19 pandemic is having a detrimental impact on substance use, mental health, and weight-related health behaviors among people with obesity, according to a new study by researchers at UT Southwestern and the UTHealth School of Public Health.
Betty Jones voted for President Donald Trump in 2016, but the lifelong Republican has her doubts she will do it again this year.
Watson Pharmaceuticals, Inc. today announced that the results of an open-label extension of two Phase 3 studies, published in the December issue of the peer-reviewed journal Urology, demonstrate long-term safety and tolerability of RAPAFLO® (silodosin) for up to 52 weeks of treatment. RAPAFLO® is an effective and uniquely selective alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), the number one reason patients visit urologists.
Cancer-related fatigue is often a major problem for cancer patients, beginning at diagnosis, during treatment and after completing therapy. Researchers at Mayo Clinic and the North Central Cancer Treatment Group (NCCTG) recently completed a study testing methylphenidate in the treatment of cancer-related fatigue and found that, while it did not improve fatigue for a broad group of patients, the data did not rule out a benefit for those with stage III/IV cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rishi Kranth Vasireddy, MBBS Po Box 955534, Saint Louis, MO 63195-5534 Ph: () - | Rishi Kranth Vasireddy, MBBS 1035 Bellevue Ave, Suite 305, Saint Louis, MO 63117-1854 Ph: (314) 925-4741 |
News Archive
Clinical Therapeutics features a special report in its April issue focusing primarily on the behavioral issues associated with patients' self-management of type 2 diabetes.
The COVID-19 pandemic is having a detrimental impact on substance use, mental health, and weight-related health behaviors among people with obesity, according to a new study by researchers at UT Southwestern and the UTHealth School of Public Health.
Betty Jones voted for President Donald Trump in 2016, but the lifelong Republican has her doubts she will do it again this year.
Watson Pharmaceuticals, Inc. today announced that the results of an open-label extension of two Phase 3 studies, published in the December issue of the peer-reviewed journal Urology, demonstrate long-term safety and tolerability of RAPAFLO® (silodosin) for up to 52 weeks of treatment. RAPAFLO® is an effective and uniquely selective alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), the number one reason patients visit urologists.
Cancer-related fatigue is often a major problem for cancer patients, beginning at diagnosis, during treatment and after completing therapy. Researchers at Mayo Clinic and the North Central Cancer Treatment Group (NCCTG) recently completed a study testing methylphenidate in the treatment of cancer-related fatigue and found that, while it did not improve fatigue for a broad group of patients, the data did not rule out a benefit for those with stage III/IV cancer.
› Verified 9 days ago
Mrs. Jetuan L Rowley-herron, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 5471 Dr Martin Luther King Dr, Saint Louis, MO 63112 Phone: 314-367-5820 Fax: 314-367-7010 | |
Amy Elizabeth Roberts, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8888 Ladue Rd Ste 210, Saint Louis, MO 63124 Phone: 314-996-5900 Fax: 314-995-5910 | |
Christopher Brian Espana, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5034 Griffin Rd, Saint Louis, MO 63128 Phone: 314-843-7333 Fax: 314-843-9946 | |
Mrs. Teresita Agustin Cometa, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 5471 Dr Martin Luther King Dr, Saint Louis, MO 63112 Phone: 314-367-5820 Fax: 314-367-6326 | |
Dr. Michael T Railey, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6125 Clayton Ave, Ste 222, Saint Louis, MO 63139 Phone: 314-768-3685 Fax: 314-768-3940 | |
Dr. Alan Valente A Padua, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13303 Tesson Ferry Rd Ste 100, Saint Louis, MO 63128 Phone: 314-722-4741 Fax: 314-722-4731 | |
Anne Usha Jacob, M.B.B.S. Family Medicine Medicare: Medicare Enrolled Practice Location: 3649 Page Blvd, Saint Louis, MO 63113 Phone: 314-288-0071 Fax: 314-758-5210 |